• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Pediatrics

ADHD stimulant treatment associated with changes in BMI trajectory

byBrandon ChildsandWilliam Raszka, MD
March 17, 2014
in Pediatrics, Psychiatry
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD/CDC/ Debora Cartagena

1. Among adolescents, unmedicated childhood attention-deficit/hyperactivity disorder (ADHD) was associated with faster BMI growth after age 10 when compared to those undiagnosed with ADHD and without stimulant treatment.

2. ADHD stimulant treatment was associated with slower rates of BMI growth in childhood, faster growth in adolescence, and elevated BMI as an adolescent.  

Evidence Rating Level: 2 (Good)   

Study Rundown: Attention-deficit/hyperactivity disorder (ADHD) is a commonly diagnosed psychiatric disorder among pediatric patients that is often treated with stimulant medication.  Previous research has indicated a potential link between ADHD and growth deficits as well as obesity. In the current study, researchers sought to further investigate the potential association between ADHD diagnosis, stimulant-treated ADHD, and timing/duration of stimulant use with childhood BMI trajectories. Results indicated that a diagnosis of ADHD alone was associated with more rapid increases in BMI after the age of 10. Stimulant use, compared to other ADHD treatments, was linked to slower growth in childhood but accelerated growth and increased BMI in late adolescence. Earlier age of stimulant use and longer stimulant treatment duration were associated with greater effects on BMI. Despite this study’s large sample size, its homogenous white population limits generalizability to a racially diverse population. Taking into account this possible link, physicians should be mindful of the medications that they prescribe to patients with ADHD and also be prepared to initiate interventions if BMI approaches unhealthy ranges.

Click to read the study, published today in Pediatrics

RELATED REPORTS

Prognostic associations of anthropometric indices vary by clinical outcomes

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

Relevant Reading: Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder

FDA approvedFor ADHD: Simtriyo (centanafadine), Jul 24, 2026→

In-Depth [retrospective cohort study]:  A total of 163 820 (50% male, 91% white, mean age = 9 years)  files from pediatric patients ages 3-18 years old were examined from the Geisinger Health System, a primary healthcare system in central and northeastern Pennsylvania. Sociodemographics, vital signs, laboratory values, procedures, and medications of each patient were extracted from medical records. Linear regression models were used to evaluate childhood BMI trajectories with respect to ADHD diagnosis, stimulant use, age of first stimulant use, and duration of stimulant use. Children with an ADHD diagnosis and stimulant use grew slower in childhood but more rapidly in adolescence (p < 0.0001). Children with an ADHD diagnosis and without stimulant use displayed rapid BMI growth after 10 years of age (p < 0.0001) compared with controls (children without an ADHD diagnosis or stimulant use). Earlier age of stimulant use and longer duration stimulant use independently associated with significantly slower initial BMI growth in childhood and increased growth in adolescence when compared to controls.

More from this author: Current BMI standards may be predictive of metabolic syndrome, Increased cognitive activity post-concussion associated with prolonged symptom duration, Early adiposity rebound associated with worse metabolic markers, Dramatic rise of gun violence seen in PG-13 movies, Increased sleep linked to lower dietary intake in children  

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: ADHDBMIstimulants
Previous Post

2 Minute Medicine Rewind March 10 – 17, 2014

Next Post

HIV infection may increase rate of HCV-related hepatic decompensation

RelatedReports

An illustration featuring a heart within a house, with a stethoscope, a scale, and medication, symbolizing heart failure home hospital care.
Cardiology

Prognostic associations of anthropometric indices vary by clinical outcomes

September 28, 2026
Weight loss collage: a smiling bearded man in an open-collared shirt beside a coiled leather belt and a plate of salad greens
Endocrinology

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

August 31, 2026
Weight management collage: a smiling middle-aged woman in a collared blouse beside a pear, a mint sprig and a coiled belt
Chronic Disease

Sleep restriction promotes weight gain in high-risk adults 

July 6, 2026
Diabetes collage: a lidded sugar bowl inside a blue paper circle, with a whole apple and a bunch of leafy greens
Endocrinology

Biweekly glucagon-like peptide-1 receptor agonist bofanglutide improves glycemic control

June 29, 2026
Next Post
New pathogenic dimorphic fungal species suggested in HIV-positive patients

HIV infection may increase rate of HCV-related hepatic decompensation

COPD associated with increased risk for nonamnestic-mild cognitive impairment

Influenza vaccine associated with lower risk of major cardiovascular events

Estimated three quarters of people with influenza are asymptomatic [Flu Watch study]

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Less social media usage is associated with improved internalizing symptoms in high-risk young adults.
  • AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality
  • In a phase 3 trial, tirzepatide reduced BMI versus placebo in adolescents with obesity and obesity-related complications
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.